Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (29862)	1/3/2000 5:41:00 PM
From: Torben Noerup Nielsen	Respond to of 32384

Tex, If Panretin and Ontak can generate $50M, that would be nice. They may need a bit of help though. But that could come from royalties and research revenues. Note that starting in January of 2001, they get at least one new royalty stream on-line. And then there's Morphelan. I agree that $50M is a magical number. If Ligand gets that much in real net earnings, a P/E of 50 will send the share price to $50 instantly and that just happens to be the magical number that would cause me to retire! Unfortunately, I'd probably be bored :-) Cheers, Torben